Annual ROE
20.12%
-22.89%-53.22%
December 1, 2024
Summary
- As of February 7, 2025, GSK annual return on equity is 20.12%, with the most recent change of -22.89% (-53.22%) on December 1, 2024.
- During the last 3 years, GSK annual ROE has fallen by -0.99% (-4.69%).
- GSK annual ROE is now -94.49% below its all-time high of 365.45%, reached on December 31, 1995.
Performance
GSK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
18.89%
-12.50%-39.82%
September 30, 2024
Summary
- As of February 7, 2025, GSK quarterly return on equity is 18.89%, with the most recent change of -12.50% (-39.82%) on September 30, 2024.
- Over the past year, GSK quarterly ROE has dropped by -37.00% (-66.20%).
- GSK quarterly ROE is now -92.59% below its all-time high of 254.79%, reached on September 30, 1995.
Performance
GSK Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
GSK ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.2% | -66.2% |
| 3 y3 years | -4.7% | -15.5% |
| 5 y5 years | -51.3% | -15.5% |
GSK ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -77.7% | at low | -83.8% | at low |
| 5 y | 5-year | -77.7% | at low | -83.8% | at low |
| alltime | all time | -94.5% | +56.7% | -92.6% | +2851.6% |
GSK ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | 20.12%(-53.2%) | - |
| Sep 2024 | - | 18.89%(-39.8%) |
| Jun 2024 | - | 31.39%(-13.6%) |
| Mar 2024 | - | 36.32%(-13.2%) |
| Dec 2023 | 43.01%(-52.4%) | 41.85%(-25.1%) |
| Sep 2023 | - | 55.89%(-52.0%) |
| Jun 2023 | - | 116.42%(+25.0%) |
| Mar 2023 | - | 93.17%(+12.0%) |
| Dec 2022 | 90.30%(+327.8%) | 83.21%(+26.0%) |
| Sep 2022 | - | 66.05%(+239.1%) |
| Jun 2022 | - | 19.48%(-12.8%) |
| Mar 2022 | - | 22.35%(+15.6%) |
| Dec 2021 | 21.11%(-25.0%) | 19.33%(-11.0%) |
| Sep 2021 | - | 21.73%(+1.4%) |
| Jun 2021 | - | 21.42%(-15.8%) |
| Mar 2021 | - | 25.43%(-10.6%) |
| Dec 2020 | 28.15%(-31.8%) | 28.43%(-14.0%) |
| Sep 2020 | - | 33.05%(-21.6%) |
| Jun 2020 | - | 42.13%(-2.2%) |
| Mar 2020 | - | 43.08%(-13.8%) |
| Dec 2019 | 41.29%(-60.0%) | 49.98%(-31.2%) |
| Sep 2019 | - | 72.69%(-45.2%) |
| Jun 2019 | - | 132.53%(+19.1%) |
| Mar 2019 | - | 111.24%(+8.1%) |
| Dec 2018 | 103.13%(+181.9%) | 102.86%(+107.1%) |
| Sep 2018 | - | 49.66%(+15.8%) |
| Jun 2018 | - | 42.90%(+78.2%) |
| Mar 2018 | - | 24.08%(-24.9%) |
| Dec 2017 | 36.59%(+185.0%) | 32.08%(-34.1%) |
| Sep 2017 | - | 48.71%(+18.3%) |
| Jun 2017 | - | 41.17%(+33.8%) |
| Mar 2017 | - | 30.76%(+109.7%) |
| Dec 2016 | 12.84%(-89.6%) | 14.67%(+359.9%) |
| Sep 2016 | - | 3.19%(+398.4%) |
| Jun 2016 | - | 0.64%(-90.3%) |
| Mar 2016 | - | 6.62%(-92.9%) |
| Dec 2015 | 123.55%(+179.7%) | 93.38%(-19.3%) |
| Sep 2015 | - | 115.68%(-2.8%) |
| Jun 2015 | - | 119.01%(-12.0%) |
| Mar 2015 | - | 135.22%(+223.3%) |
| Dec 2014 | 44.18%(-38.3%) | 41.82%(-30.2%) |
| Sep 2014 | - | 59.93%(-8.1%) |
| Jun 2014 | - | 65.21%(-6.3%) |
| Mar 2014 | - | 69.57%(-6.9%) |
| Dec 2013 | 71.56%(+22.9%) | 74.74%(+40.3%) |
| Sep 2013 | - | 53.27%(-2.0%) |
| Jun 2013 | - | 54.37%(+1.5%) |
| Mar 2013 | - | 53.55%(-4.8%) |
| Dec 2012 | 58.23%(-1.2%) | 56.27%(-5.0%) |
| Sep 2012 | - | 59.24%(-0.3%) |
| Jun 2012 | - | 59.44%(+7.5%) |
| Mar 2012 | - | 55.28%(-4.9%) |
| Dec 2011 | 58.91%(+279.1%) | 58.14%(+63.7%) |
| Sep 2011 | - | 35.51%(+6.3%) |
| Jun 2011 | - | 33.41%(+83.1%) |
| Mar 2011 | - | 18.25%(+16.0%) |
| Dec 2010 | 15.54%(-73.5%) | 15.73%(-59.4%) |
| Sep 2010 | - | 38.78%(-7.2%) |
| Jun 2010 | - | 41.80%(-31.2%) |
| Mar 2010 | - | 60.78%(-1.9%) |
| Dec 2009 | 58.63%(+9.8%) | 61.94%(+9.2%) |
| Sep 2009 | - | 56.74%(+3.3%) |
| Jun 2009 | - | 54.93%(+3.3%) |
| Mar 2009 | - | 53.20%(-1.7%) |
| Dec 2008 | 53.39%(-1.4%) | 54.14%(+3.2%) |
| Sep 2008 | - | 52.47%(+1.6%) |
| Jun 2008 | - | 51.63%(+3.7%) |
| Mar 2008 | - | 49.81%(-3.0%) |
| Dec 2007 | 54.14%(-13.0%) | 51.35%(-2.9%) |
| Sep 2007 | - | 52.88%(-3.7%) |
| Jun 2007 | - | 54.93%(-4.6%) |
| Mar 2007 | - | 57.55%(-4.8%) |
| Dec 2006 | 62.26%(-9.4%) | 60.44%(-4.7%) |
| Sep 2006 | - | 63.41%(-2.2%) |
| Jun 2006 | - | 64.83%(-4.9%) |
| Mar 2006 | - | 68.14%(-2.1%) |
| Dec 2005 | 68.74% | 69.60%(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2005 | - | 69.42%(-2.1%) |
| Jun 2005 | - | 70.91%(-3.1%) |
| Mar 2005 | - | 73.20%(+11.9%) |
| Dec 2004 | 53.19%(-1.8%) | 65.41%(-1.4%) |
| Sep 2004 | - | 66.37%(+8.0%) |
| Jun 2004 | - | 61.47%(+2.3%) |
| Mar 2004 | - | 60.11%(+5.2%) |
| Dec 2003 | 54.19%(+10.3%) | 57.14%(-7.6%) |
| Sep 2003 | - | 61.82%(+12.1%) |
| Jun 2003 | - | 55.17%(+2.5%) |
| Mar 2003 | - | 53.85%(+7.4%) |
| Dec 2002 | 49.13%(+40.4%) | 50.15%(+3.5%) |
| Sep 2002 | - | 48.44%(+15.9%) |
| Jun 2002 | - | 41.80%(+6.7%) |
| Mar 2002 | - | 39.18%(+12.9%) |
| Dec 2001 | 35.00%(-48.7%) | 34.70%(-19.9%) |
| Sep 2001 | - | 43.30%(-12.2%) |
| Jun 2001 | - | 49.32%(-0.4%) |
| Mar 2001 | - | 49.54%(-15.4%) |
| Dec 2000 | 68.16%(+13.2%) | 58.56%(+17.9%) |
| Sep 2000 | - | 49.69%(-8.8%) |
| Jun 2000 | - | 54.46%(-7.1%) |
| Mar 2000 | - | 58.60%(-15.0%) |
| Dec 1999 | 60.19%(-23.8%) | 68.94%(+4.8%) |
| Sep 1999 | - | 65.77%(-22.9%) |
| Jun 1999 | - | 85.26%(+12.6%) |
| Mar 1999 | - | 75.70%(-27.3%) |
| Dec 1998 | 78.96%(-31.2%) | 104.10%(+25.2%) |
| Sep 1998 | - | 83.18%(+11.8%) |
| Jun 1998 | - | 74.37%(-19.7%) |
| Mar 1998 | - | 92.62%(+30.8%) |
| Dec 1997 | 114.73%(-54.1%) | 70.79%(-60.7%) |
| Sep 1997 | - | 180.15%(+15.3%) |
| Jun 1997 | - | 156.25%(+1.3%) |
| Mar 1997 | - | 154.23%(+142.4%) |
| Dec 1996 | 249.92%(-31.6%) | 63.62%(-74.8%) |
| Mar 1996 | - | 252.77%(-0.8%) |
| Dec 1995 | 365.45%(+885.8%) | - |
| Sep 1995 | - | 254.79%(+761.7%) |
| Jun 1995 | - | 29.57%(+40.5%) |
| Jun 1995 | 37.07%(+42.6%) | - |
| Mar 1995 | - | 21.05%(-3.9%) |
| Dec 1994 | - | 21.91%(-6.5%) |
| Sep 1994 | - | 23.44%(-22.5%) |
| Jun 1994 | 26.00%(-7.6%) | 30.24%(+7.3%) |
| Mar 1994 | - | 28.19%(-2.8%) |
| Dec 1993 | - | 28.99%(+3.9%) |
| Sep 1993 | - | 27.89%(-16.7%) |
| Jun 1993 | 28.15%(-5.2%) | 33.48%(+26.2%) |
| Mar 1993 | - | 26.53%(+1.5%) |
| Dec 1992 | - | 26.13%(-0.2%) |
| Sep 1992 | - | 26.19%(-29.7%) |
| Jun 1992 | 29.70%(-7.2%) | 37.28%(+0.8%) |
| Mar 1992 | - | 37.00%(+5.1%) |
| Dec 1991 | - | 35.21%(+5.4%) |
| Sep 1991 | - | 33.42%(-21.3%) |
| Jun 1991 | 32.01%(+3.3%) | 42.49%(+36.4%) |
| Mar 1991 | - | 31.14%(+3.0%) |
| Dec 1990 | - | 30.23%(+3.2%) |
| Sep 1990 | - | 29.30%(-32.5%) |
| Jun 1990 | 31.00%(-12.5%) | 43.43%(+14.1%) |
| Mar 1990 | - | 38.07%(+8.6%) |
| Dec 1989 | - | 35.07%(+3.7%) |
| Sep 1989 | - | 33.83%(-22.1%) |
| Jun 1989 | 35.43%(-5.4%) | 43.41%(+14.5%) |
| Mar 1989 | - | 37.91%(+2.7%) |
| Dec 1988 | - | 36.93%(+4.3%) |
| Sep 1988 | - | 35.40%(-19.4%) |
| Jun 1988 | 37.47%(-2.7%) | 43.94%(+8.3%) |
| Mar 1988 | - | 40.57%(+1.5%) |
| Dec 1987 | - | 39.99%(+7.6%) |
| Sep 1987 | - | 37.18%(+8.6%) |
| Jun 1987 | 38.50%(-8.0%) | 34.25%(-18.5%) |
| Mar 1987 | - | 42.03%(+9.6%) |
| Dec 1986 | - | 38.34%(+3.1%) |
| Sep 1986 | - | 37.20%(+5.5%) |
| Jun 1986 | 41.85% | 35.27% |
FAQ
- What is GSK annual return on equity?
- What is the all time high annual ROE for GSK?
- What is GSK annual ROE year-on-year change?
- What is GSK quarterly return on equity?
- What is the all time high quarterly ROE for GSK?
- What is GSK quarterly ROE year-on-year change?
What is GSK annual return on equity?
The current annual ROE of GSK is 20.12%
What is the all time high annual ROE for GSK?
GSK all-time high annual return on equity is 365.45%
What is GSK annual ROE year-on-year change?
Over the past year, GSK annual return on equity has changed by -22.89% (-53.22%)
What is GSK quarterly return on equity?
The current quarterly ROE of GSK is 18.89%
What is the all time high quarterly ROE for GSK?
GSK all-time high quarterly return on equity is 254.79%
What is GSK quarterly ROE year-on-year change?
Over the past year, GSK quarterly return on equity has changed by -37.00% (-66.20%)